Psychological distress (symptoms of anxiety and depression) Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 29/05/2025: 1. University students aged between 17-29 years old; 2. score = 5.5 on the Patient Health Questionnaire-9 (PHQ-9); 3. willing to attend five sessions of SH+. _____ Previous inclusion criteria : 1. University students 2. Aged between 17-24 years old 3. Increased levels of psychological distress based on the Kessler psychological distress scale-10 items (K10; K10 =18)
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 29/05/2025: 1. Acute medical conditions that require immediate hospitalization. 2. Score = 20 (severe depression symptoms) on the PHQ-9 3. Indication of imminent risk of suicide or self-harm or other life-threatening risk based on Suicide Ideation Scale (SIS) with score = 21.89. 4. Indication of severe cognitive impairment related to a mental, neurological or substance abuse based on PM+ observation checklist. 5. Initiated, stopped, or significantly modified pharmacotherapy in the last eight weeks. 6. Initiated or stopped specialized psychological treatment (e.g., Cognitive Behavioural Therapy, psychoanalytic therapy) in the last eight weeks. _____ Previous exclusion criteria: 1. Acute medical conditions that require immediate hospitalization. 2. Shows imminent suicide risk or self-harm or other life-threatening risk based on interview based on the question of imminent risk of suicide from Problem Management Plus (PM+) manual 3. Indication of severe cognitive impairment related to a mental, neurological or substance abuse based on PM+ observation checklist; and 4. Initiated, stopped, or significantly modified pharmacotherapy in the last eight weeks. 5. Initiated or stopped specialized psychological treatment (e.g., Cognitive Behavioural Therapy, psychoanalytic therapy) in the last eight weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psychological distress as measured by the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) total score. It will be administered at baseline, 1-week post-intervention, 3- (primary end point) and 6-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline, 1-week post-intervention, 3- and 6-month follow-up 1. Symptoms of depression will be measured with Patient Health Questionnaire (PHQ-9) 2. Symptoms of anxiety will be measured by General Anxiety Disorder (GAD-7) 3. Perceived stress will be measured by Perceived Stress Scale (PSS) 4. General functioning measured by WHO Disability Assessment 2.0 (WHODAS 2.0) 5. Quality of life will be measured by EQ-5D-5L 6. Exposure to objective microstressors will be measured by the Mainz Inventory of Microstressors (MIMIS), which will be adapted for the current population 7. Self-identified problems measured using the PSYCHLOPS Added 06/08/2024: 8. Cost-effectiveness from analysis of EQ-5D-5L and Client Service Receipt Inventory (CSRI) | — |
Countries
Indonesia